Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk Equivalents.

Next Previous
X
Search
Trial Profile

Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk Equivalents.

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Torcetrapib/atorvastatin (Primary) ; Atorvastatin
  • Indications Coronary disorders; Myocardial infarction; Stroke; Unstable angina pectoris
  • Focus Registrational; Therapeutic Use
  • Acronyms ILLUMINATE
  • Sponsors Pfizer

    • Most Recent Events

    • 07 Apr 2022 This trial has been completed in Spain (Global end date: 29/04/2007), according to European Clinical Trials Database record.
    • 01 Feb 2022 Results from ctp:700008441 and ctp:248832 published in the Arteriosclerosis Thrombosis and Vascular Biology
    • 03 Oct 2017 Results of a retrospective proteomics analysis using plasma samples (n=472) from the Illuminate trial, published in the Circulation.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top